Giarre, M., Semenov, M.V., and Brown, A.M.C. Wnt signaling stabilizes the dual function protein beta-catenin in diverse cell types. Ann. N.Y. Acad. Sci. 857: 43-55, 1998.

Howe, L.R., Subbaramaiah, K., Chung, W.J., Dannenberg, A.J., Brown, A.M.C. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res. 59: 1572-1577, 1999.

Kuraguchi, M., Edelmann, W., Yang, K., Lipkin, M., Kucherlapati, R., and Brown, A.M.C. (2000) Tumor-associated Apc mutations in Mlh1-/-Apc1638N mice reveal a mutational signature of Mlh1 deficiency. Oncogene, 19, 5755-5763.

Howe, L.R., Crawford, H., Hassell, J.A., Dannenberg, A.J., and Brown, A.M.C. (2001) PEA3 is upregulated in response to Wnt-1 and regulates the Cyclooxygenase-2 promoter. J. Biol. Chem., 276, 20108-20115.

Brown, A.M.C. (2001) Wnt signaling in breast cancer: have we come full circle? Breast Cancer Research 3, 351-355.

You, Z., Saims, D., Chen, S., Zhang, Z., Guttridge D.C., Guan, K-L., MacDougald, O.A., Brown, A.M.C., Evan, G., Kitajewski J., Wang, C-Y. (2002) Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J. Cell. Biol., 157, 429-440.

Howe, L. R., Subbaramaiah, K., Patel, J., Masferrer, J. L., Deora, A., Hudis, C., Thaler, H. T., Muller, W. J., Du, B., Brown, A. M. C., and Dannenberg, A. J. (2002) Celecoxib, a selective cyclooxygenase-2 inhibitor, protects against HER-2/neu-induced breast cancer. Cancer Res, 62, 5405-5407.

Wong, E., Yang, K., Kuraguchi, M., Werling, U., Avdievich, A., Fan, K., Fazzari, M., Jin, B., Brown, A.M.C., Lipkin, M., and Edelmann, W. (2002) Mbd4 inactivation increases C→T transition mutations and promotes gastrointestinal tumor formation. Proc. Natl. Acad. Sci. (U.S.A.), 99, 14937-14942.

Brennan, K.R., and Brown, A.M.C. (2003) Is there a role for Notch signaling in human breast cancer? Breast Cancer Res., 5, 69-75.

Howe, L.R., Watanabe, O., Leonard, J., and Brown, A.M.C. (2003) Twist is upregulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res., 63, 1906-1913.

Anakwe, K., Robson, L., Hadley, J., Buxton, P., Church, V., Allen, S., Hartmann, C., Harfe, B., Nohno, T., Brown, A.M.C., Evans, D.J.R., and Francis-West, P. (2003) Wnt signalling regulates myogenic differentiation in the developing avian wing. Development, 130, 3503-3514.

Howe, L.R., and Brown, A.M.C. (2004) Wnt signaling and breast cancer. Cancer Biol. Ther. 3, 36-41.

Brennan, K., Gonzalez-Sancho, J.M., Castelo-Soccio, L.A., Howe, L.R., and Brown, A.M.C. (2004) Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize β-catenin independently of Frizzled proteins. Oncogene, 23, 4873-4884.

Gonz‡lez-Sancho, J.M., Brennan, K.R., Castelo-Soccio, L.A., and Brown, A.M.C. (2004) Wnt proteins induce Dishevelled phosphorylation via an LRP5/6-independent mechanism, irrespective of their ability to stabilize β-catenin. Mol. Cell Biol., 24, 4757-4768.

Brennan, K., and Brown, A.M.C. (2004) Wnt proteins in mammary development and cancer. J. Mamm. Gland Biol. Neoplasia, 9, 119-131.

Brown, A.M.C. (2005) Canonical Wnt signaling: high-throughput RNAi widens the path. Genome Biol. 6, 231.1-231.4.

Howe, L. R., Chang, S-H., Tolle, K.C., Dillon, R., Young, L.J.T., Cardiff, R.D., Newman, R.A., Yang, P., Thaler, H.T., Muller, W.J., Hudis, C., Brown, A.M.C., Hla, T., Subbaramaiah, K., and Dannenberg, A. J. (2005) HER2/neu-Induced mammary tumorigenesis and angiogenesis are reduced in Cyclooxygenase-2 knockout mice. Cancer Res. 65, 10113-10119.